Lifecore Biomedical (LFCR), announced that the Board of Directors of the Company intends to initiate a process to evaluate the company’s potential strategic alternatives to maximize value for stockholders.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
